Mesothelioma News

Asbestos Workers Union Joins New Medical Foundation's Quest for Cure of Asbestos and Benzene-Related Cancers
The Pacific Heart, Lung and Blood Institute is pleased to announce the addition of Terry Lynch as a member of its Board of Directors.

Alfacell Achieves Full Patient Enrollment Milestone for the ONCONASE Phase IIIb Registration Study in Unresectable
Alfacell Corporation today announced that the full enrollment target of 316 patients has been reached for the international, confirmatory Phase IIIb registration trial evaluating ONCONASE , the Company's lead investigational drug candidate, as a treatment for unresectable malignant mesothelioma .

$1 million of mesothelioma research funding
The Mesothelioma Applied Research Foundation (MARF) has announced awards of almost $1 million in additional research funding aimed at curing mesothelioma.